{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:12:28Z","timestamp":1774617148219,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T00:00:00Z","timestamp":1498176000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10792-017-0618-z","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T07:51:54Z","timestamp":1498204314000},"page":"1549-1558","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion"],"prefix":"10.1007","volume":"38","author":[{"given":"Havva Erdogan","family":"Kald\u0131r\u0131m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serpil","family":"Yazgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,23]]},"reference":[{"key":"618_CR1","first-page":"133","volume":"98","author":"R Klein","year":"2000","unstructured":"Klein R, Klein BE, Moss SE, Meuer SM (2000) The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98:133\u2013141 discussion 141\u2013143","journal-title":"Trans Am Ophthalmol Soc"},{"key":"618_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/02713680701851902","volume":"33","author":"J Rehak","year":"2008","unstructured":"Rehak J, Rehak M (2008) Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 33:111\u2013131. doi: 10.1080\/02713680701851902","journal-title":"Curr Eye Res"},{"key":"618_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.eye.6702498","volume":"22","author":"H Noma","year":"2008","unstructured":"Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, Hirayama T, Tamura H, Yamashita H, Minamoto A, Mishima HK (2008) Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular edema in branch retinal vein occlusion. Eye (Lond) 22:42\u201348. doi: 10.1038\/sj.eye.6702498","journal-title":"Eye (Lond)"},{"key":"618_CR4","first-page":"2627","volume":"40","author":"KH Chen","year":"1999","unstructured":"Chen KH, Wu CC, Roy S, Lee SM, Liu JH (1999) Increased interleukin-6 in aqueous humor of neovascular glaucoma. Invest Ophthalmol Vis Sci 40:2627\u20132632","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"618_CR5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480\u20131487","journal-title":"N Engl J Med"},{"issue":"6","key":"618_CR6","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1167\/iovs.14-13961","volume":"55","author":"H Noma","year":"2014","unstructured":"Noma H, Mimura T, Yasuda K, Shimura M (2014) Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema. Invest Ophthalmol Vis Sci 55(6):3878\u20133885","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"618_CR7","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ajo.2011.03.033","volume":"152","author":"HJ Sohn","year":"2011","unstructured":"Sohn HJ, Han DH, Kim IT et al (2011) Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Am J Ophthalmol 152(4):686\u2013694","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"618_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.sjopt.2011.01.003","volume":"25","author":"PA Keane","year":"2011","unstructured":"Keane PA, Sadda SR (2011) Predicting visual outcomes for macular disease using optical coherence tomography. Saudi J Ophthalmol 25(2):145\u2013158. doi: 10.1016\/j.sjopt.2011.01.003","journal-title":"Saudi J Ophthalmol"},{"key":"618_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/OPTH.S40079","volume":"7","author":"T Ota","year":"2013","unstructured":"Ota T, Tsujikawa A, Murakami T, Ogino K, Muraoka Y, Kumagai K, Akagi-Kurashige Y, Miyamoto K, Yoshimura N (2013) Subfoveal serous retinal detachment associated with extramacular branch retinal vein occlusion. Clin Ophthalmol 7:237\u2013241. doi: 10.2147\/OPTH.S40079","journal-title":"Clin Ophthalmol"},{"key":"618_CR10","doi-asserted-by":"crossref","unstructured":"The Branch Retinal Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch retinal vein occlusion. Am J Ophthalmol 98(3):271\u2013282","DOI":"10.1016\/0002-9394(84)90316-7"},{"key":"618_CR11","doi-asserted-by":"publisher","unstructured":"Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH; SCORE Study Research Group (2009) A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 127:1101-1114. doi: 10.1001\/archophthalmol.2009.234","DOI":"10.1001\/archophthalmol.2009.234"},{"key":"618_CR12","doi-asserted-by":"publisher","unstructured":"Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; for the OZURDEX GENEVA Study Group (2011) Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 118:2453-2460. doi: 10.1016\/j.ophtha.2011.05.014","DOI":"10.1016\/j.ophtha.2011.05.014"},{"key":"618_CR13","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.ophtha.2011.02.022","volume":"118","author":"DM Brown","year":"2011","unstructured":"Brown DM, Campochiaro PA, Bhisitkul RB, Ho AC, Gray S, Saroj N, Adamis AP, Rubio RG, Murahashi WY (2011) Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion:12-month outcomes of a phase III study. Ophthalmol 118:1594\u20132049. doi: 10.1016\/j.ophtha.2011.02.022","journal-title":"Ophthalmol"},{"key":"618_CR14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archophthalmol.2009.233","volume":"127","author":"IU Scott","year":"2009","unstructured":"Scott IU, Ip MS, VanVeldhuisen PC et al (2009) SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intra-vitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6. Arch Ophthalmol 127:1115\u20131128","journal-title":"Arch Ophthalmol"},{"key":"618_CR15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0161-6420(98)93020-2","volume":"105","author":"J Pe\u2019er","year":"1998","unstructured":"Pe\u2019er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E (1998) Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 105:412\u2013416","journal-title":"Ophthalmology"},{"key":"618_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ophtha.2008.09.034","volume":"116","author":"H Noma","year":"2009","unstructured":"Noma H, Funatsu H, Mimura T, Harino S, Hori S (2009) Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology 116:87\u201393. doi: 10.1016\/j.ophtha.2008.09.034","journal-title":"Ophthalmology"},{"issue":"1102\u20131112","key":"618_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.ophtha.2010.02.021","volume":"117","author":"PA Campochiaro","year":"2010","unstructured":"Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG, Investigators BRAVO (2010) Ranibizumab for macular edema following branch retinal vein occlusion: 6-month primary end point results of a phase III study. Ophthalmology 117(1102\u20131112):e1. doi: 10.1016\/j.ophtha.2010.02.021","journal-title":"Ophthalmology"},{"key":"618_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ophtha.2014.08.031","volume":"122","author":"PA Campochiaro","year":"2015","unstructured":"Campochiaro PA, Clark WL, Boyer DS, Heier JS, Brown DM, Vitti R, Kazmi H, Berliner AJ, Erickson K, Chu KW, Soo Y, Cheng Y, Haller JA (2015) Intravitreal aflibercept for macular edema following branch retinal vein occlusion: 24-week results of the V\u0130BRANT study. Ophthalmology 122:538\u2013544. doi: 10.1016\/j.ophtha.2014.08.031","journal-title":"Ophthalmology"},{"key":"618_CR19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-2999(97)01464-7","volume":"341","author":"M Nauck","year":"1998","unstructured":"Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M (1998) Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 341:309\u2013315","journal-title":"Eur J Pharmacol"},{"key":"618_CR20","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1089\/jop.2014.0141","volume":"31","author":"E Unsal","year":"2015","unstructured":"Unsal E, Eltutar K, Sultan P, Gungel H (2015) The efficiency of intravitreal dexamethasone implants in the treatment of macular edema secondary to retinal vein occlusion. J Ocul Pharmacol Ther 31:350\u2013356. doi: 10.1089\/jop.2014.0141","journal-title":"J Ocul Pharmacol Ther"},{"key":"618_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000381187","volume":"53","author":"F Bandello","year":"2015","unstructured":"Bandello F, Parravano M, Cavallero E, Cascavilla ML, Triolo G, Querques L, Borrelli E, Giorno P, Varano M, Lattanzio R, Querques G (2015) Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex\u00ae)for retinal vein occlusion. Ophthalmic Res 53:207\u2013216. doi: 10.1159\/000381187","journal-title":"Ophthalmic Res"},{"key":"618_CR22","doi-asserted-by":"publisher","unstructured":"Dugel PU, Capone A Jr, Singer MA Dreyer RF, Dodwell DG, Roth DB, Shi R, Walt JG, Scott LC, Hollander DA; SHASTA Study Group (2015) Two or more dexamethasone intravitreal implants in treatment-na\u00efve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study. BMC Ophthalmol. 15:118. doi: 10.1186\/s12886-015-0106-z","DOI":"10.1186\/s12886-015-0106-z"},{"key":"618_CR23","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2147\/OPTH.S107594","volume":"10","author":"Y Sakanishi","year":"2016","unstructured":"Sakanishi Y, Lee A, Usui-Ouchi A, Ito R, Ebihara N (2016) 12-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab. Clin Ophthalmol. 10:1161\u20131165. doi: 10.2147\/OPTH.S107594","journal-title":"Clin Ophthalmol."},{"key":"618_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5301\/ejo.5000637","volume":"26","author":"E Yumusak","year":"2016","unstructured":"Yumusak E, Buyuktortop N, Ornek K (2016) Early results of dexamethasone implant, ranibizumab, and triamcinolone in macular edema due to branch retinal vein occlusion. Eur J Ophthalmol 26:54\u201359. doi: 10.5301\/ejo.5000637","journal-title":"Eur J Ophthalmol"},{"key":"618_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ophtha.2015.09.035","volume":"123","author":"WL Clark","year":"2016","unstructured":"Clark WL, Boyer DS, Heier JS, Brown DM, Haller JA, Vitti R, Kazmi H, Berliner AJ, Erickson K, Chu KW, Soo Y, Cheng Y, Campochiaro PA (2016) Intravitreal Aflibercept for macular edema following branch retinal vein occlusion: 52-week results of the vibrant study. Ophthalmology 123:330\u2013336. doi: 10.1016\/j.ophtha.2015.09.035","journal-title":"Ophthalmology"},{"issue":"1","key":"618_CR26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10792-016-0226-3","volume":"37","author":"K Manousaridis","year":"2017","unstructured":"Manousaridis K, Peter S, Mennel S (2017) Outcome of intravitreal dexamethasone implant for the treatment of ranibizumab-resistant macular edema secondary to retinal vein occlusion. Int Ophthalmol 37(1):47\u201353","journal-title":"Int Ophthalmol"},{"key":"618_CR27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ophtha.2011.12.005","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier JS, Campochiaro PA, Yau L, Li Z, Saroj N, Rubio RG, Lai P (2012) Ranibizumab for macular edema due to retinal vein occlusion: long-term follow-up in the horizon trial. Ophthalmology 119:802\u2013809. doi: 10.1016\/j.ophtha.2011.12.005","journal-title":"Ophthalmology"},{"key":"618_CR28","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1016\/j.ophtha.2014.06.011","volume":"121","author":"PA Campochiaro","year":"2014","unstructured":"Campochiaro PA, Wykoff CC, Singer M, Johnson R, Marcus D, Yau L, Sternberg G (2014) Monthly versus as-need ranibizumab injections in patients with retinal vein occlusion: the shore study. Ophthalmology 121:2432\u20132442. doi: 10.1016\/j.ophtha.2014.06.011","journal-title":"Ophthalmology"},{"key":"618_CR29","doi-asserted-by":"publisher","first-page":"e007527","DOI":"10.1136\/bmjopen-2014-007527","volume":"5","author":"SA Regnier","year":"2015","unstructured":"Regnier SA, Larsen M, Bezlyak V, Allen F (2015) Comparative efficacy and safety of approved treatments for macular oedema secondary to branch retinal vein occlusion: a network meta-analysis. BMJ Open 5:e007527. doi: 10.1136\/bmjopen-2014-007527","journal-title":"BMJ Open"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-017-0618-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0618-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0618-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T15:03:15Z","timestamp":1569510195000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-017-0618-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,23]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["618"],"URL":"https:\/\/doi.org\/10.1007\/s10792-017-0618-z","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,23]]}}}